Advertisement
Biological Psychiatry
Advanced searchSave search
Brief report| Volume 34, ISSUE 3, P188-190, August 01, 1993

Download started.

Ok

Frontal cortex lesions modify the cataleptogenic properties of haloperidol but not of clozapine

  • George E. Jaskiw
    Correspondence
    Address reprint requests to: Dr. George E. Jaskiw, Psychiatry Service 116A(B), Cleveland VAMC, 10000 Brecksville Rd., Cleveland, OH 44141.
    Affiliations
    From the Psychobiology Dept., case Western Reserve University, Cleveland, OH, USA

    the Brecksville Veterans Administration Medical Center, Brecksville, OH, USA.
    Search for articles by this author
  • Ghazala Hussain
    Affiliations
    From the Psychobiology Dept., case Western Reserve University, Cleveland, OH, USA

    the Brecksville Veterans Administration Medical Center, Brecksville, OH, USA.
    Search for articles by this author
  • Herbert Y. Meltzer
    Affiliations
    From the Psychobiology Dept., case Western Reserve University, Cleveland, OH, USA

    the Brecksville Veterans Administration Medical Center, Brecksville, OH, USA.
    Search for articles by this author
DOI:https://doi.org/10.1016/0006-3223(93)90390-Y
Frontal cortex lesions modify the cataleptogenic properties of haloperidol but not of clozapine
Previous ArticleAcute effects of neuroleptics on unmedicated schizophrenic patients and controls
Next ArticlePolysomnographic characteristics of schizophrenia in comparison with mania and depression
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Ashby Jr., C.R.
        • Wang R.Y.
        Effects of antipsychotic drugs on 5HT2 receptors in the medial prefrontal cortex: microiontophoretic studies.
        Brain Res. 1990; 506: 346-348
        • Burki H.R.
        • Sayers A.C.
        • Ruch W.
        • Asper H.
        Effects of clozapine and other dibenzo-epines on central dopaminergic and cholinergic systems.
        Arzneimittelforschung (Drug Res). 1977; 27: 1561-1565
        • Casey D.E.
        Clozapine: Neuroleptic-induced EPS and tardive dyskenesia.
        Psychopharmacology. 1989; 99 ([suppl]): 47-53
        • Costall B.
        • Naylor R.J.
        Neuroleptic and non-neuroleptic catalepsy.
        Arzneimittelforschung (Drug Res). 1973; 23: 674-683
        • Coward D.M.
        • Imperato A.
        • Urwyler S.
        • White T.G.
        Biochemical and behavioural properties of clozapine.
        Psychopharmacology. 1989; 99 ([suppl]): 6-12
        • Honna T.
        • Fukushima H.
        Effects of bilateral lesions in the striatum or nucleus accumbens on the cataleptogenic activity of neuroleptics in rats.
        Jpn J Pharmacol. 1978; 28: 231-238
        • Jaskiw G.E.
        • Karoum F.K.
        • Freed W.J.
        • Kleinman J.
        • Weinberger D.R.
        Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat.
        Brain Res. 1990; 534: 263-272
        • Klockgether T.
        • Schwarz M.
        • Turski L.
        • Sontag K.-H.
        Catalepsy after microinjection into the rat medial prefrontal cortex.
        Exp Brain Res. 1988; 70: 445-447
        • Krieg W.J.S.
        Connections of the cerebral cortex. I. The albino rat. Topography of the cortical areas.
        J Comp Neurol. 1946; 84: 222-275
        • Louilot A.
        • Le Moal M.
        • Simon H.
        Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens. An in vivo voltammetric study.
        Neuroscience. 1989; 29: 45-56
        • Moghaddam B.
        • Bunney B.S.
        Acute effect of typical and atypical neuroleptics on release of dopamine in prefrontal cortex, nucleus accumbens and striatum of the rat.
        J Neurochem. 1990; 54: 1755-1760
        • Paxinos G.
        • Watson C.
        The Rat Brain in Stereotactic Coordinates.
        Academic Press, Orlando, FL1986
        • Pickar D.
        • Hsiao J.
        • Litman R.E.
        • et al.
        Local cerebral glucose metabolism and its relationship to clozapine response.
        Am Coll Neuropsychopharmacol. 1991; 81 (Abstracts)
        • Robertson G.S.
        • Fibiger H.C.
        Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of Haloperidol and clozapine.
        Neuroscience. 1992; 46: 315-328
        • Sanberg R.
        Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors.
        Nature. 1980; 284: 472-473
        • Sesack S.R.
        • Bunney B.S.
        Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: A microiontophoretic study.
        J Pharmacol Exp Ther. 1989; 248: 1232-1333
        • Worms P.
        • Willigens M.-T.
        • Continsouza-Blanc D.
        • Lloyd K.G.
        The effect of different types of cortical lesions on drug-induced catalepsy in rats: a pharmacological analysis.
        Eur J Pharmacol. 1985; 113: 53-59

      Article info

      Publication history

      Received in revised form: April 16, 1993
      Received: October 3, 1992

      Identification

      DOI: https://doi.org/10.1016/0006-3223(93)90390-Y

      Copyright

      © 1993 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX